These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33995080)

  • 1. Gaseous Mediators as a Key Molecular Targets for the Development of Gastrointestinal-Safe Anti-Inflammatory Pharmacology.
    Danielak A; Wallace JL; Brzozowski T; Magierowski M
    Front Pharmacol; 2021; 12():657457. PubMed ID: 33995080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs.
    Wallace JL; Vong L
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1151-6. PubMed ID: 18951293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TRENDS IN DEVELOPMENT OF GI-SAFE ANTI-INFLAMMATORY DRUGS].
    Sulaieva ON; Wallace JL
    Klin Med (Mosk); 2017; 95(3):222-7. PubMed ID: 30303341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaseous mediators nitric oxide and hydrogen sulfide in the mechanism of gastrointestinal integrity, protection and ulcer healing.
    Magierowski M; Magierowska K; Kwiecien S; Brzozowski T
    Molecules; 2015 May; 20(5):9099-123. PubMed ID: 25996214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaseous mediator-based anti-inflammatory drugs.
    Sulaieva O; Wallace JL
    Curr Opin Pharmacol; 2015 Dec; 25():1-6. PubMed ID: 26319186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaseous Mediators in Gastrointestinal Mucosal Defense and Injury.
    Wallace JL; Ianaro A; de Nucci G
    Dig Dis Sci; 2017 Sep; 62(9):2223-2230. PubMed ID: 28733867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaseous mediators in resolution of inflammation.
    Wallace JL; Ianaro A; Flannigan KL; Cirino G
    Semin Immunol; 2015 May; 27(3):227-33. PubMed ID: 26095908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide-based therapies: focus on H2S releasing NSAIDs.
    Fiorucci S; Santucci L
    Inflamm Allergy Drug Targets; 2011 Apr; 10(2):133-40. PubMed ID: 21275896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome Profile and Molecular Pathways Alterations in Gastrointestinal Tract by Hydrogen Sulfide-Releasing Nonsteroidal Anti-Inflammatory Drug (ATB-352): Insight into Possible Safer Polypharmacy.
    Głowacka U; Magierowska K; Wójcik D; Hankus J; Szetela M; Cieszkowski J; Korbut E; Danielak A; Surmiak M; Chmura A; Wallace JL; Magierowski M
    Antioxid Redox Signal; 2022 Feb; 36(4-6):189-210. PubMed ID: 33678013
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction between endogenous carbon monoxide and hydrogen sulfide in the mechanism of gastroprotection against acute aspirin-induced gastric damage.
    Magierowski M; Magierowska K; Hubalewska-Mazgaj M; Adamski J; Bakalarz D; Sliwowski Z; Pajdo R; Kwiecien S; Brzozowski T
    Pharmacol Res; 2016 Dec; 114():235-250. PubMed ID: 27825819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon Monoxide Being Hydrogen Sulfide and Nitric Oxide Molecular Sibling, as Endogenous and Exogenous Modulator of Oxidative Stress and Antioxidative Mechanisms in the Digestive System.
    Korbut E; Brzozowski T; Magierowski M
    Oxid Med Cell Longev; 2020; 2020():5083876. PubMed ID: 32377300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building a better aspirin: gaseous solutions to a century-old problem.
    Wallace JL
    Br J Pharmacol; 2007 Oct; 152(4):421-8. PubMed ID: 17641669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments.
    Chan MV; Wallace JL
    Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G467-73. PubMed ID: 23868410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs.
    Fiorucci S; Distrutti E
    Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergisms, Discrepancies and Interactions between Hydrogen Sulfide and Carbon Monoxide in the Gastrointestinal and Digestive System Physiology, Pathophysiology and Pharmacology.
    Głowacka U; Brzozowski T; Magierowski M
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32183095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Gastric Mucosal Protection Against Stress-induced Gastric Lesions. Importance of Renin-angiotensin Vasoactive Metabolites, Gaseous Mediators and Appetite Peptides.
    Brzozowski T; Magierowska K; Magierowski M; Ptak-Belowska A; Pajdo R; Kwiecien S; Olszanecki R; Korbut R
    Curr Pharm Des; 2017; 23(27):3910-3922. PubMed ID: 28228069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide-releasing anti-inflammatory drugs.
    Wallace JL
    Trends Pharmacol Sci; 2007 Oct; 28(10):501-5. PubMed ID: 17884186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.